Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001964306-25-000020
Filing Date
2025-01-21
Accepted
2025-01-21 16:24:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3610
  Complete submission text file 0001964306-25-000020.txt   5062
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Subject) CIK: 0001576885 (see all company filings)

EIN.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40551 | Film No.: 25542760
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ACUMEN PHARMACEUTICALS, INC. 427 PARK STREET CHARLOTTESVILLE VA 22902
Business Address
OConnell Daniel Joseph (Reporting) CIK: 0001865136 (see all company filings)

Type: 144